Design, Synthesis, and Evaluation of Novel Syncarpic Acid Derivatives as Potential Anti‐Inflammatory Agents
ChemMedChem · 14.05.2026 · 21 (9)
DOI: 10.1002/cmdc.70306 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, online erschienen am 14.05.2026. Verfasst von Revoju Sravanthi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Catalysis Laboratory, School of Chemistry, University of Hyderabad, Hyderabad, India. Hauptthemen laut MEDLINE: Drug Design, Anti-Inflammatory Agents, Non-Steroidal, Antioxidants, Anti-Inflammatory Agents. Die Arbeit nennt 39 Literaturangaben. Gefördert von: Department of Science and Technology, Ministry of Science and Technology, India.
Abstract (Originalsprache)
Inflammation is a complex immune response driven by oxidative stress and proinflammatory mediators that promote tissue damage and disease progression. Although syncarpic acid exhibits antioxidant therapeutic potential, its clinical utility is limited by suboptimal efficacy and poor pharmacological properties. In the current study, we synthesized novel 4‐alkyl/aryl‐syncarpic acid derivatives using organocatalytic reductive C ‐alkylation and Rh‐catalyzed α ‐arylation of cyclic iodonium ylides, achieving yields ranging from good to excellent. Furthermore, the antioxidant and anti‐inflammatory potential of these compounds was evaluated using the DPPH radical scavenging assay, DCFDA assay, RT‐qPCR, and Western blot analysis in RAW 264.7 and BEAS‐2B cell lines. Our findings demonstrated that compounds 5c and 9a exhibited markedly higher antioxidant and anti‐inflammatory activity compared to other syncarpic acid derivatives. Western blot analysis further revealed that compounds 5c and 9a exert their anti‐inflammatory effects, at least in part, by modulating the MAPK signaling pathway. Acute toxicity studies indicate that compound 9a exhibits a favorable safety profile while retaining significant antioxidant activity. Overall, these results indicated that the syncarpic acid derivatives 5c and 9a exhibit potent anti‐inflammatory efficacy and acceptable safety margins, supporting their potential therapeutic application in inflammatory disorders such as acute respiratory distress syndrome (ARDS) and ulcerative colitis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Catalysis Laboratory, School of Chemistry, University of Hyderabad, Hyderabad, India.
- Department of Pharmaceutical Chemistry, GITAM School of Pharmacy, GITAM (Deemed to be University), Visakhapatnam, India.
- Department of Applied Biology, CSIR-Indian Institute of Chemical Technology, Hyderabad, Telangana, India.
ORCID-Profile: Sai Balaji Andugulapati, Dhevalapally B Ramachary
Förderung
- Department of Science and Technology, Ministry of Science and Technology, India
Zitieren
APA
Sravanthi, R., Kambhampati, V., Eedara, A., Andugulapati, S. B., & Ramachary, D. B. (2026). Design, Synthesis, and Evaluation of Novel Syncarpic Acid Derivatives as Potential Anti‐Inflammatory Agents. ChemMedChem, 21(9). https://doi.org/10.1002/cmdc.70306
Vancouver
Sravanthi R, Kambhampati V, Eedara A, Andugulapati SB, Ramachary DB. Design, Synthesis, and Evaluation of Novel Syncarpic Acid Derivatives as Potential Anti‐Inflammatory Agents. ChemMedChem. 2026;21(9). doi:10.1002/cmdc.70306
BibTeX
@article{Sravanthi2026,
author = {Sravanthi, Revoju and Kambhampati, Vaishnavi and Eedara, Abhisheik and Andugulapati, Sai Balaji and Ramachary, Dhevalapally B},
title = {Design, Synthesis, and Evaluation of Novel Syncarpic Acid Derivatives as Potential Anti‐Inflammatory Agents},
journal = {ChemMedChem},
year = {2026},
volume = {21},
number = {9},
doi = {10.1002/cmdc.70306}
}
EUVIMED